NCT03020108View on ClinicalTrials.gov

Serum Caspase 3, Annexin a2 and Soluble Fas Levels and Endometriosis

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

August 31, 2017

Conditions
EndometriosisApoptotic Pathway Deregulation
Interventions
OTHER

Blood sample

2 cc blood samples will be drawn from antecubital vein

Trial Locations (1)

34250

Bakirkoy Dr Sadi Konuk Teaching and Research Hospital, Department of Obstetrics and Gynecology, Istanbul

All Listed Sponsors
lead

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

OTHER_GOV

NCT03020108 - Serum Caspase 3, Annexin a2 and Soluble Fas Levels and Endometriosis | Biotech Hunter | Biotech Hunter